Elevation of transforming growth factor beta (TGFβ) and its downstream mediators in subcutaneous foreign body capsule tissue

Journal of Biomedical Materials Research - Part A

Volumn 82, Issue 2, 2007, Pages 498-508

  Li, Allen G ^a   Quinn, Matthew J ^b   Siddiqui, Yasmin ^a   Wood, Michael D ^b   Federiuk, Isaac F ^b   Duman, Heather M ^b   Ward, W Kenneth ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LEGACY RESEARCH   (United States)

Author keywords

Biosensor; Collagen; Foreign body capsule; Implantation; Smad; Transforming growth factor beta

Indexed keywords

BIOMEDICAL DEVICES; FIBROTIC RESPONSE; TRANSFORMING GROWTH FACTORS;

BIOSENSORS; COLLAGEN; ENCAPSULATION; FIBROBLASTS; IMPLANTS (SURGICAL); PHOSPHORYLATION; RATS; TISSUE;

TISSUE ENGINEERING;

COLLAGEN; RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSENSOR; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FIBROBLAST; FIBROSIS; FOREIGN BODY REACTION; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MALE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS;

ANIMALS; CELL COUNT; COLLAGEN TYPE I; FIBROBLASTS; FOREIGN-BODY REACTION; MALE; MATERIALS TESTING; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34447299678     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31168     Document Type: Article

References (67)

1. Ward WK, Slobodzian EP, Tiekotter KL, Wood ML. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 2002;23:4185-4192.
2. Ratner BD. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 2002;78:211-218.
3. Coleman DL, King RN, Andrade JD. The foreign body reaction: A chronic inflammatory response. J Biomed Mater Res 1974;8:199-211.
4. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401-412.
5. Wisniewski N, Moussy F Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000;366:611-621.
6. Ward WK, Casey HM, Quinn MJ, Federiuk IF, Wood MD. A fully implantable subcutaneous glucose sensor array: Enhanced accuracy from multiple sensing units and a median-based algorithm. Diabetes Technol Ther 2003;5:943-952.
7. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically-implanted amperometric glucose sensor. Diabetes Technol Ther 2004;6:137-145.
8. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. Closed loop glycemic control in ketosis-prone rats with a chronic subcutaneous glucose sensor. Artif Organs 2005;29:131-143.
9. Ward WK, Wood MD, Troupe JE. Rise in background current over time in a subcutaneous glucose sensor in the rabbit: Relevance to calibration and accuracy. Biosens Bioelectron 2000;15:53-61.
10. Ward WK, Troupe JE. Assessment of chronically implanted subcutaneous glucose sensors in dogs: The effect of surrounding fluid masses. ASAIO J 1999;45:555-561.
11. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
12. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J 2004;18:816-827.
13. Mauviel A. Transforming growth factor-β: A key mediator of fibrosis. Methods Mol Med 2005;117:69-80.
14. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
15. Lawrence DA. Identification and activation of latent transforming growth factor B. Methods Enzymol 1991;198:327-336.
16. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003;425:577-584.
17. Feng XH, Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 2005;21:659-693.
18. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783-2810.
19. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
20. Goto D, Yagi K, Inoue H, Iwamoto I, Kawabata M, Miyazono K, Kato M. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-β signals. FEBS Lett 1998;430:201-204.
21. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997;94:10669-10674.
22. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 2002;7:1191-1204.
23. Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, Ten Dijke P, Heldin CH. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 1997;272:28107-28115.
24. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000;1:169-178.
25. Ten Dijke P, Hill CS. New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004;29:265-273.
26. Izzi L, Attisano L. Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation. Oncogene 2004;23:2071-2078.
27. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol Cell 2000;6:1365-1375.
28. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-746.
29. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor B in human disease. N Engl J Med 2000;342:1350-1358.
30. Ward WK, Quinn MJ, Wood MD, Tiekotter KL, Pidikiti S, Gallagher JA. Vascularizing the tissue surrounding a model biosensor: How localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? Biosens Bioelectron 2003;19:155-163.
31. Luna LG. Connective and muscle tissue. In: Freida L, editor. Histotechnology: A Self-Instructional Text. Chicago: ASCP Press; 1997. p 131-156.
32. Li AG, Wang D, Feng XH, Wang XJ. Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004;23:1770-1781.
33. Li AG, Lu SL, Zhang MX, Deng C, Wang XJ. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res 2004;64:7836-7845.
34. He W, Li AG, Wang D, Han S, Zheng B, Goumans MJ, Ten Dijke P, Wang XJ. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J 2002;21:2580-2590.
35. Iordanov MS, Choi RJ, Ryabinina OP, Dinh TH, Bright RK, Magun BE. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol Cell Biol 2002;22:5380-5394.
36. Kruger NJ. The Bradford method for protein quantitation. Methods Mol Biol 1994;32:9-15.
37. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004;4:583-594.
38. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-503.
39. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122: 103-111.
40. Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A 2003;64:320-329.
41. Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Halle JP. Inflammatory response to peritoneal implantation of alginate-poly-L- lysine microcapsules. Biomaterials 2005;26:4119-4127.
42. Robitaille R, Desbiens K, Henley N, Halle JP. Time course of transforming growth factor-β(1) (TGF-β(1)) mRNA expression in the host reaction to alginate-poly-L-lysine microcapsules following implantations into rat epididymal fat pads. J Biomed Mater Res 2000;52:18-23.
43. Roberts AB, Russo A, Felici A, Flanders KC. Smad3: A key player in pathogenetic mechanisms dependent on TGF-β. Ann N Y Acad Sci 2003;995:1-10.
44. O'Kane S, Ferguson MW. Transforming growth factor-βs and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
45. Varga J. Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-1713.
46. Zhang K, Garner W, Cohen L, Rodriguez J, Phan S. Increased types I and III collagen and transforming growth factor-β1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 1995;104:750-754.
47. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 1996;74:991-1003.
48. Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A. Conditional epidermal expression of TGFβ1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 2001;98:9139-9144.
49. Tredget EB, Demare J, Chandran G, Tredget EE, Yang L, Ghahary A. Transforming growth factor-β and its effect on re-epithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen 2005;13:61-67.
50. Yang L, Chan T, Demare J, Iwashina T, Ghahary A, Scott PG, Tredget EE. Healing of burn wounds in transgenic mice overexpressing transforming growth factor-β1 in the epidermis. Am J Pathol 2001;159:2147-2157.
51. Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A. Role of elevated plasma transforming growth factor-β1 levels in wound healing. Am J Pathol 1999;154:1115-1124.
52. Hetzel M, Bachem M, Anders D, Trischler G, Faehling M. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 2005;183:225-237.
53. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990;63:515-524.
54. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002;62:1149-1159.
55. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGFβ/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001;276:17058-17062.
56. Wang M, Zhao D, Spinetti G, Zhang J, Jiang LQ, Pintus G, Monticone R, Lakatta EG. Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 2006;26:1503-1509.
57. Philipp K, Riedel F, Germann G, Hormann K, Sauerbier M. TGF-β antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells. Int J Mol Med 2005;15:299-303.
58. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-β by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev 2000;11:59-69.
59. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-β 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107(Part 5):1137-1157.
60. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor β responses in skin fibroblasts. Arthritis Rheum 2004;50:4008-4021.
61. Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α 2(I)-collagen (COL1A2) transcription. J Biol Chem 2000;275:39237-39245.
62. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002;160:1057-1068.
63. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, Wang XJ, DiPietro LA, Varga J. Targeted disruption of TGF-β/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 2004;165:203-217.
64. Grainger D, Koenig A. Cell adhesion-dependent signaling pathways on biomaterials surfaces. In: Dillow AK, Lowman M, editors. Biomimetic Materials and Design. New York: Marcel Dekker; 2002. p 87.
65. Brown R, Ormsby I, Greenhalgh DG. Wound healing in the transforming growth factor-β1-deficient mouse. Wound Repair Regen 1995;3:25-36.
66. Letterio JJ, Roberts AB. Transforming growth factor-β1-deficient mice: Identification of isoform-specific activities in vivo. J Leukoc Biol 1996;59:769-774.
67. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108(Part 3):985-1002.